Nov 6 (Reuters) - Moberg Pharma AB (publ) MBPH.ST :
* MOBERG PHARMA DECIDES ON FULLY GUARANTEED RIGHTS ISSUE OF
APPROXIMATELY SEK 150 MILLION
* PROCEEDS WILL BE USED FOR REGISTRATION ACTIVITIES AND
CLINICAL
WORK FOR MOB-015
* WHEN RIGHTS ISSUE IS COMPLETED, COMPANY INTENDS TO
TERMINATE
CURRENT CONVERTIBLE NOTE AGREEMENT
* FINAL TERMS FOR RIGHTS ISSUE, INCLUDING SUBSCRIPTION
PRICE, ARE
EXPECTED TO BE ANNOUNCED NOT LATER THAN ON NOVEMBER 27, 2020
* RIGHTS ISSUE REQUIRES APPROVAL OF AN EXTRAORDINARY GENERAL
MEETING
* SUBSCRIPTION PERIOD IS EXPECTED TO COMMENCE ON DEC 7, 2020
UP TO
AND INCLUDING DEC 21, 2020, OR SUCH LATER DATE RESOLVED BY BOARD
Source text for Eikon: ID:nWkrl19kS
Further company coverage: MBPH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))